Activation of Kir4.1/Kir5.1 contributes to the cyclosporin A‐induced stimulation of the renal NaCl cotransporter and hyperkalemic hypertension
Acta Physiologica · 2023
DOI: 10.1111/apha.13948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2023. Verfasst von Zhong-Xiuzi Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Medicine Integrated Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Hyperkalemia, Hypertension. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Aim
Cyclosporin A (CsA) is a widely used immunosuppressive drug that causes hypertension and hyperkalemia. Moreover, CsA‐induced stimulation of the thiazide‐sensitive NaCl cotransporter (NCC) in the kidney has been shown to be responsible for the development of hyperkalemic hypertension. In this study, we tested whether CsA induces the activation of NCC by stimulating the basolateral Kir4.1/Kir5.1 channel in the distal convoluted tubule (DCT).
Methods
Electrophysiology, immunoblotting, metabolic cages, and radio‐telemetry methods were used to examine the effects of CsA on Kir4.1/Kir5.1 activity in the DCT, NCC function, and blood pressure in wild‐type (WT) and kidney‐specific Kir4.1 knockout (KS‐Kir4.1 KO) mice.
Results
The single‐channel patch clamp experiment demonstrated that CsA stimulated the basolateral 40 pS K + channel in the DCT. Whole‐cell recording showed that short‐term CsA administration (2 h) not only increased DCT K + currents but also shifted the K + current ( I K ) reversal potential to the negative range (hyperpolarization). Furthermore, CsA administration increased phosphorylated NCC (pNCC) levels and inhibited renal Na + and K + excretions in WT mice but not in KS‐Kir4.1 KO mice, suggesting that Kir4.1 is required to mediate CsA effects on NCC function. Finally, long‐term CsA infusion (14 days) increased blood pressure, plasma K + concentration, and total NCC or pNCC abundance in WT mice, but these effects were blunted in KS‐Kir4.1 KO mice.
Conclusion
We conclude that CsA stimulates basolateral K + channel activity in the DCT and that Kir4.1 is essential for CsA‐induced NCC activation and hyperkalemic hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Traditional Chinese Medicine Integrated Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Institute of Nephrology, Zhengzhou University, Zhengzhou, China.
- Henan Province Research Center for Kidney Disease, Zhengzhou, China.
- Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
ORCID-Profile: Peng Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
Zitieren
APA
Gao, Z. X., Zhou, R., Li, M. Y., Li, S. T., Mao, Z. H., Shu, T. T., Liu, D. W., Liu, Z. S., & Wu, P. (2023). Activation of Kir4.1/Kir5.1 contributes to the cyclosporin A‐induced stimulation of the renal NaCl cotransporter and hyperkalemic hypertension. Acta Physiologica. https://doi.org/10.1111/apha.13948
Vancouver
Gao ZX, Zhou R, Li MY, Li ST, Mao ZH, Shu TT, et al. Activation of Kir4.1/Kir5.1 contributes to the cyclosporin A‐induced stimulation of the renal NaCl cotransporter and hyperkalemic hypertension. Acta Physiologica. 2023. doi:10.1111/apha.13948
BibTeX
@article{Gao2023,
author = {Gao, Zhong-Xiuzi and Zhou, Rui and Li, Ming-Yan and Li, Shu-Ting and Mao, Zi-Hui and Shu, Ting-Ting and Liu, Dong-Wei and Liu, Zhang-Suo and Wu, Peng},
title = {Activation of Kir4.1/Kir5.1 contributes to the cyclosporin A‐induced stimulation of the renal NaCl cotransporter and hyperkalemic hypertension},
journal = {Acta Physiologica},
year = {2023},
doi = {10.1111/apha.13948}
}
EUVIMED